SweetValueLab
Write for us

Solventum Corporation — Financial Statements & Ratios

SOLV
NYSEHealthcareMedical - Instruments & SuppliesCIK 0001964738solventum.comAbout SOLV
Last close · Oct 16, 202685.81−2.05 (−2.33%)
Market cap$14.6B

Key indicators

Revenue8.3BTTM−0.9% on a year earlier+0.8% a year, FY2022–FY2025
Fiscal yearFY2022FY2023FY2024FY2025TTMFY2026EFY2027EFY2028E
Growth
8.1B 8.2B+0.8%8.3B+0.7%8.3B+0.9%8.3B−0.9%8.2B 8.5B 8.9B
— 0.8% 0.7% 0.9% -0.9% -1.1% 3.6% 4.0%
$7.78 $7.79+0.1%$2.76−64.6%$8.88+221.7%$8.19+277.4%$7.16 $7.33 $8.07
Profitability
57.7% 57.3%−0.5 pt55.6%−1.6 pt53.5%−2.2 pt54.7%+0.2 pt· · ·
20.8% 20.6%−0.2 pt12.6%−8.1 pt26.2%+13.6 pt25.0%+15.7 pt· · ·
16.5% 16.4%−0.1 pt5.8%−10.6 pt18.7%+12.9 pt17.3%+12.7 pt· · ·
11.4% 11.5%+0.1 pt16.2%+4.7 pt30.8%+14.6 pt— · · ·
Cash
1.4B 1.6B+13.8%805.0M−50.5%-10.0M−101.2%-118.0M−180.3%· · ·
17.6% 19.8%+2.3 pt9.8%−10.1 pt-0.1%−9.9 pt-1.4%−3.2 pt· · ·
Balance sheet
— — 2.71x 1.00x−1.71x1.06x−1.09x· · ·
172.70M 172.70M+0.0%173.70M+0.6%175.30M+0.9%173.30M−1.1%· · ·

E = analyst consensus (revenue and EPS only). TTM = the twelve months to Jun 30, 2026: the last fiscal year, plus the quarters since, less the same quarters a year earlier. From the 10-K and the 10-Qs since, as accepted by the SEC; the shaded column is the latest period.